Pharmacologic and Genetic Evaluation of a C. Elegans Model for Migraine
Phase of Trial: Phase I/II
Latest Information Update: 25 Aug 2015
At a glance
- Drugs Ethosuximide (Primary)
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Pharmacogenomic; Therapeutic Use
- 15 Feb 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Jan 2012 Planned end date changed from 1 Jan 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.